anonymous
Guest
anonymous
Guest
The shit show continues:
Obesity drug shortage expands to Saxenda as Novo Nordisk warns of limited supply for 2023 and beyond
Obesity drug shortage expands to Saxenda as Novo Nordisk warns of limited supply for 2023 and beyond